2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$64.92+$0.006 (+0.009%)
Price as of Nov 12, 2026 8:49 AM EST- $5.4BMarket Cap
- -13.40%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$64.92+$0.006 (+0.009%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $64.91 | ||
Change | +$0.77 (+1.20%) | ||
Open | $64.03 | ||
High | $65.04 | ||
Low | $63.62 | ||
Previous Close | $64.14 | ||
Volume | 724,937 | ||
30-Day Average Volume | 1,115,064 | ||
1-Week Change | -5.89% | ||
1-Month Change | 0.32% | ||
1-Year Change | -13.40% | ||
3-Year Change | 250.11% | ||
5-Year Change | 63.46% | ||
Fundamentals | |||
Shares Outstanding | 83.5M | ||
Total Assets | $3.2B | ||
Market Cap | $5.4B | ||
Enterprise Value | $5.7B | ||
Period: QTR TTM FY | |||
Revenue | $275.9M | ||
Net Income | -$51.7M | ||
Free Cash Flow | -$28.0M | ||
EBIT | $4.8M | ||
EBITDA | $21.6M | ||
Net Working Capital | $1.8B | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | 266 | ||
Enterprise Value/Revenue | 21 | ||
P/B | -28 | ||
P/E | -105 | ||
PEG | 1 | ||
Price/Free Cash Flow | -194 | ||
Price/Operating Cash Flow | -214 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue